Global

‡ In these countries please contact our distributor

About RENASYS

This information is intended for HCPs in the US.
Please consult your local Smith + Nephew representative for further details on products available in your market. 

 

Powerfully simple NWPT

An easy-to-use, cost-effective platform to deliver effective NPWT to acute and post-acute patients with complex wounds1-3 

RENASYS Negative Pressure Wound Therapy Systems focus on the simplified delivery of advanced therapy for a wide range of complex wounds. Designed to be intuitive, user-friendly, and cost effective, while supporting optimized clinical outcomes.1-4 

The human and economic burden of chronic wounds

  • In the US, 6.5 million patients are affected by chronic wounds5 
  • Wound-related complications cost the healthcare system $25B annually5
  • 68% of patients with a chronic leg ulcer have reported a negative impact on their life, including loneliness and isolation6 

Two pumps, one platform…for all care settings

To help cut through the complexity of NPWT, RENASYS tNPWT enables a seamless transition from acute to home care settings.

 

RENASYS TOUCH tNPWT System – Acute settings

Shown to deliver proven clinical outcomes in the time taken to achieve a treatment goal, percentage reduction in wound area, and weekly rate of reduction in wound area.3 

 

 

RENASYS GO tNPWT – Outpatient and home care settings

Powerful and portable NPWT for ambulatory and post-acute patients with complex wounds. Sleek, quiet, and lightweight to offer care, confidence, and mobility.

Distributed through Rotech Healthcare Inc.

 

How does RENASYS tNPWT compare to V.A.C.™?

A study comparing RENASYS tNPWT to V.A.C.™ found no statistical difference in achieving treatment milestones in the percentage reduction in wound area and weekly rate of reduction in wound area.*3 

 

Find out more 

 

 Variable intermittent mode offers a range of pressure and time cycle settings to help stimulate granulation and manage pain.1,2,7

Watch: the effect of intermittent NPWT on local microcirculation  

 
OneNPWT portfolio – simple just got simpler

One compelling solution to meet your negative pressure wound therapy needs at every stage of the wound care journey.1,4,8-12 

For additional guidance on product selection, visit OneNPWT 

 

Ordering information and support

For further information and guidance, please contact us

For ordering information (RENASYS GO), contact your local Rotech® Healthcare Inc sales representative

For system availability (RENASYS GO), consult the WoundExpert® electronic health records

Helping you get CLOSER TO ZERO delay in wound healing.1

 

Important Safety Information

The information herein is intended for healthcare professionals. RENASYS is contraindicated in the presence of untreated osteomyelitis, exposed arteries/veins/organs/nerves, necrotic tissue with eschar present, malignancy in the wound, non-enteric and unexplored fistulas, and exposed anastomotic sites. Excessive bleeding is a serious risk associated with the application of suction to wounds, which may result in death or serious injury. For full product and safety information, please see the Instructions for Use.

The PICO 7 pump contains a MAGNET. Keep the PICO 7 pump at least 4 inches (10 cm) away from other medical devices at all times. Failure to do so can cause the other medical devices to fail which can result in serious harm including death. Excessive bleeding is a serious risk associated with the application of suction to wounds, which may result in death or serious injury. The risk information provided herein is not comprehensive. For full product and safety information, please see the Instructions for Use.

 

*Large retrospective study on NPWT (n=1107).

All trademarks acknowledged.

 

References:

1.    Forlee M, Richardson J, Rossington A, Cockwill J, Smith J. An interim analysis of device functionality and usability of RENASYS™ TOUCH – a new portable Negative Pressure Wound Therapy (NPWT) system. Paper presented at: Wounds UK; 2016; Harrogate, UK.
2.    Forlee M, van Zyl L, Louw V, Nel J, Fourie N, Hartley R. A randomised controlled trial to compare the clinical effi cacy and acceptability of adjustable intermittent and continuous Negative Pressure Wound Therapy (NPWT) in a new portable NPWT system. Paper presented at: EWMA; 2018; Krakow, Poland.
3.    Hurd T, Rossington A, Trueman P, Smith J. A Retrospective Comparison of the Performance of Two Negative Pressure Wound Therapy Systems in the Management of Wounds of Mixed Etiology. Advances in Wound Care. 2017;6(1):33–37.
4.    Smith & Nephew January 2018. Outcomes following PICO compared to conventional dressings when used prophylactically on closed surgical incisions: systematic literature review and meta-analysis. Internal Report. EO/AWM/PICO/004/v1.
5.    Jarbrink K, Ni G, Sonnergren H, et al. Prevalence and incidence of chronic wounds and related complications: a protocol for a systematic review. Syst Rev. 2016;5:152.
6.    Phillips T, Stanton B, Provan A, Lew R. A study of the impact of leg ulcers on quality of life: fi nancial, social, and psychologic implications. J Am Acad Dermatol. 1994;31(1):49–53.
7.    Smith & Nephew 2016. Smith and Nephew’s RENASYS™ Touch Device Features
– Adjustable Settings. Internal Report. DS.16.138.R.11.
8.    Hurd T, Chadwick P, Cote J, et al. Impact of gauze-based NPWT on the patient and nursing experience in the treatment of challenging wounds. International Wound Journal. 2010;7(6):448-455.
9.    Kantar Health market research report, November 2018.
10.    O’leary DP, Peirce C, Anglim B, et al.Prophylactic Negative Pressure Dressing Use in Closed Laparotomy Wounds Following Abdominal Operations: A Randomized, Controlled, Open-label Trial: The P.I.C.O. Trial. Ann Surg. 2017;265(6):1082-1086.
11.    Selvaggi F, Pellino G, Sciaudone G, et al.New Advances in Negative Pressure Wound Therapy (NPWT) for Surgical Wounds of Patients Affected with Crohn’s Disease. Surgical Technology International. 2014;24:83-89.
12.    Karlakki SL, Hamad AK, Whittall C, et al.Incisional negative pressure wound therapy dressings (iNPWTd) in routine primary hip and knee arthroplasties: A randomised controlled trial. Bone Joint Res. 2016;5(8):328-337.
13.    Dowsett C, et al. Use of PICO to improve clinical and economic outcomes in hard-to-heal wounds. Wounds International. 2017;8, p53–58.
14.    Kirsner R, Dove C, Reyzelman A, Vayser D, Jaimes H. A prospective, randomized, controlled clinical trial on the efficacy of a single-use negative pressure wound therapy system, compared to traditional negative pressure wound therapy in the treatment of chronic ulcers of the lower extremities. Wound Repair Regen. 2019 Sept;27(5):519-529.
Important Safety Information

 

The information herein is intended for healthcare professionals. RENASYS is contraindicated in the presence of untreated osteomyelitis, exposed arteries/veins/organs/nerves, necrotic tissue with eschar present, malignancy in the wound, non-enteric and unexplored fistulas, and exposed anastomotic sites. Excessive bleeding is a serious risk associated with the application of suction to wounds, which may result in death or serious injury. For full product and safety information, please see the Instructions for Use.

How does RENASYS compare to V.A.C.™?

Find out more

RENASYS◊  GO
Post-Acute NPWT Solution in the United States

Order your RENASYS GO pump in the US through Rotech Healthcare, Inc.

Download now

Intended for HCPs in the US only